“Evaluation of Natural Killer Activated Receptor NKG2D, Inhibitory Receptor KIR2DL1 and Soluble Ligand MICA in Iraqi Patients of Acute Myeloid Leukemia”. Journal of Pharmaceutical Negative Results, vol. 13, Oct. 2022, pp. 148-55, https://doi.org/10.47750/pnr.2022.13.S05.21.